NCT03789396View on ClinicalTrials.gov

Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients

CompletedOBSERVATIONAL
Enrollment

572

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 19, 2019

Study Completion Date

October 1, 2022

Conditions
TraumaCritical IllnessOxygen Toxicity
Interventions
OTHER

Targeted Normoxia (oxygen saturation 90-96%)

The intervention (post-implementation) group will be trauma patients admitted to the ICU during the 6 months after the targeted normoxia implementation

OTHER

Usual Care Oxygenation

The control (pre-implementation) group will be trauma patients admitted to the ICU during the 12 months prior to the targeted normoxia implementation

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Colorado, Denver

OTHER

NCT03789396 - Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients | Biotech Hunter | Biotech Hunter